Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by rgonlyfactsplson Jun 27, 2013 7:14pm
246 Views
Post# 21577897

Just crossed my screen...

Just crossed my screen...
June 27, 2013 6:46 PM

Concerned Bioniche Shareholders Call Special Meeting of Shareholders to Replace Bioniche's Board

-Special Meeting Called Following Bioniche Board's Dereliction of its Fiduciary and Statutory Duties and Failure to Call a Properly Requisitioned Special Meeting of Shareholders

-Bioniche Shareholders Invited to learn more and Join the Concerned Shareholder Campaign for A Better Future for Bioniche by visiting www.savebioniche.com and Registering Support for the Concerned Shareholders

TORONTO, June 27, 2013 /CNW/ - The Concerned Shareholders of Bioniche Life Sciences Inc. ("Bioniche"), William (Bill) M. Wells, former Chief Executive Officer of Biovail Corporation, and Greg Gubitz, former General Counsel and Senior Vice President of Corporate Development at Biovail Corporation (the "Concerned Shareholders"), announced that pursuant to section 143(4) of the Canada Business Corporations Act ("CBCA") Mr. Wells has called a Special Meeting of the Bioniche Shareholders so shareholders can have the opportunity to vote to replace the Board of Directors with seven independent nominees nominated by the Concerned Shareholders.

https://www.newswire.ca/en/story/1191879/concerned-bioniche-shareholders-call-special-meeting-of-shareholders-to-replace-bioniche-s-board

<< Previous
Bullboard Posts
Next >>